Aspiration Pneumonia in Older Adults

Area of Science:

• Pulmonology
• Infectious Diseases
• Critical Care Medicine

Background:

• Aspiration pneumonia is a lung infection caused by inhaling endogenous flora.
• Diagnosis involves risk factors, clinical presentation, and imaging (radiography or ultrasound).

Purpose of the Study:

• To outline diagnostic criteria and treatment strategies for aspiration pneumonia.
• To differentiate treatment based on community- vs. healthcare-associated acquisition and risk factors.

Main Methods:

• Review of diagnostic criteria and treatment guidelines for aspiration pneumonia.
• Categorization of treatment based on community-acquired aspiration pneumonia (CAAP) vs. healthcare-associated aspiration pneumonia (HCAAP).
• Consideration of multidrug-resistant (MDR) organisms, Pseudomonas aeruginosa (PA), methicillin-resistant Staphylococcus aureus (MRSA), and severity of illness.

Main Results:

• Treatment for CAAP without severe illness or MDR risk involves standard anaerobic coverage.
• CAAP with risk factors for MDR pathogens, septic shock, ICU admission, or ventilation requires broader coverage (anaerobes, MRSA, PA).
• Severe HCAAP or HCAAP with MDR risk factors necessitates similar broad coverage, with double PA coverage for severe HCAAP with additional risk factors.

Conclusions:

• Treatment protocols for aspiration pneumonia must be tailored to the specific clinical context.
• Further research is needed, particularly in antibiotic stewardship, to optimize management.
• Understanding and managing aspiration pneumonia requires ongoing investigation into antibiotic resistance and therapeutic efficacy.